FilingSEC EDGAR8-K
Neuphoria Therapeutics Extends Rights Agreement Expiration Date by One Year
· SEC accepted
StageN/A
Filing content
The company entered into an amendment to its existing rights agreement, extending the final expiration date to October 27, 2027.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…